/Investor DB

5AM Ventures — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

hC Biosciencehcbioscience.comFeb 2022Defunct

Cambridge, MA biotech developing engineered tRNA "protein editing" therapeutics for nonsense-mutation diseases; reported shut down in 2025.

Cambridge, US

Leslie J Williams(Executive Officer, Director)

BoardBenjamin Chen(Director)Seiji Miyahara(Director)inSacha Mann(Director)David Moskowitz(Director)Steven Gillis(Director)in

Co-investorsARCH Venture Partners8VCAtlas VenturePanacea VentureTaiho Ventures, LLCTakeda Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Fellow Health

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.